Sign in
4

Changes in Ownership

X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-022084

Director acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lawton Alison Frances Director 2023-06-13 Grant or award +45,000 51,667 D
Loading xslF345X04/wk-form4_1686775872.xml…